Remission can occur because of treatment, or it can happen spontaneously. For example, symptoms of autoimmune diseases like ...

About 2.7 million people in the U.S. live with inflammatory bowel diseases, which cause long-term inflammation in the ...

Medically reviewed by Jay N. Yepuri, MD Inflammatory bowel disease (IBD) is a group of chronic (long-term) conditions that cause inflammation in the digestive tract, which includes the mouth, ...

An expert on ulcerative colitis and Crohn's explains how drug interchangeability works, how effective biosimilar drugs can be, and what it all means for patients with a range of inflammatory ...

Crohn’s disease affects the digestive tract, but patients may also experience extraintestinal manifestations (EIMs) or complications. This refers to complications outside of the intestines.

In patients with small intestinal Crohn’s disease (CD), there is a need for a simple, non-invasive test to reduce dependence on invasive procedures (eg, enteroscopy) and costly imaging (eg, MRI or CT ...

InflaRx ends its Phase 3 trial of vilobelimab in pyoderma gangrenosum and shifts focus to INF904 amid efforts to extend its cash runway.

InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.

How brain stimulation alleviates symptoms of Parkinson's disease Date: May 27, 2025 Source: Ruhr-University Bochum Summary: Persons with Parkinson's disease increasingly lose their mobility over ...

A male patient aged 28 years with an 8-year history of ileal Crohn’s disease was started on combination therapy with infliximab and azathioprine 12 months ago. He was maintained on infliximab at a ...

Abstract Chronic inflammatory bowel diseases (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), are characterized by persistent gastrointestinal inflammation influenced by genetic, ...